Antigen presentation to T cells in nonlymphoid tissue
Antigen presentation to T cells in nonlymphoid tissue
批准号:
7213343
负责人:
James B McLachlan
金额:
$3.23万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-01 至 2007-09-30
中文摘要
描述(由申请人提供):已经证实,抗原在次级淋巴器官的呈递对于抗原特异性适应性免疫反应的启动是必不可少的。这种反应的初级阶段包括树突状细胞在MHC II环境下的抗原呈递,然后被CD4+ T细胞识别,CD4+ T细胞反过来被激活。活化的效应CD4+ T细胞迁移回抗原沉积的部位,在那里它们可以停留数周。本研究旨在确定抗原呈递在非淋巴组织中的作用及其对CD4+ T细胞的影响。虽然我们预计组织中的炎症环境同样会启动效应T细胞的进入,但我们假设,为了实现最大的积累、隔离和持续激活,抗原特异性T细胞必须在抗原沉积的实际位置识别MHC II背景下的同源抗原。我们的假设是,当树突状细胞激活淋巴结中的T细胞时,组织中的巨噬细胞负责抗原沉积部位的抗原呈递以及CD4+ T细胞的持续激活和保留。
英文摘要
DESCRIPTION (provided by applicant): It has been well established that antigen presentation in secondary lymphoid organs is essential for the initiation of an antigen specific adaptive immune response. The primary phase of this response consists of antigen presentation by dendritic cells in the context of MHC II where it is then recognized by CD4+ T cells which in turn can become activated. Activated effector CD4+ T cells migrate back into sites of antigen deposition where they can remain for weeks. This proposal seeks to determine the role of antigen presentation in nonlymphoid tissues with respect to its effect on CD4+ T cells. While we expect that the inflammatory milieu in the tissue initiates the entry of effector T cells equally, we hypothesize that in order for maximal accumulation, sequestration, and sustained activation to occur, antigen-specific T cells must recognize cognate antigen in the context of MHC II at the actual site of antigen deposition. Our hypothesis is that while dendritic cells activate T cells in the lymph nodes, macrophages in the tissue is responsible for antigen presentation at the site of antigen deposition and for the sustained activation and retention of CD4+ T cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using combination adjuvants to direct and control immune responses at the intestinal mucosa
-
批准号:9108588
-
项目类别:
-
资助金额:$39.33万
-
财政年份:2016
-
负责人:James B McLachlan
-
依托单位:
Mast cell control of endogenous, antigen-specific CD4 T cell immunity
-
批准号:9019796
-
项目类别:
-
资助金额:$22.58万
-
财政年份:2016
-
负责人:James B McLachlan
-
依托单位:
Using combination adjuvants to direct and control immune responses at the intestinal mucosa
-
批准号:9247816
-
项目类别:
-
资助金额:$54.66万
-
财政年份:2016
-
负责人:James B McLachlan
-
依托单位:
Using combination adjuvants to direct and control immune responses at the intestinal mucosa
-
批准号:9897616
-
项目类别:
-
资助金额:$38.07万
-
财政年份:2016
-
负责人:James B McLachlan
-
依托单位:
Organ-specific CD4 T cell responses regulate Salmonella persistence
-
批准号:8868025
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2013
-
负责人:James B McLachlan
-
依托单位:
Organ-specific CD4 T cell responses regulate Salmonella persistence
-
批准号:8703005
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2013
-
负责人:James B McLachlan
-
依托单位:
Organ-specific CD4 T cell responses regulate Salmonella persistence
-
批准号:9085228
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2013
-
负责人:James B McLachlan
-
依托单位:
Organ-specific CD4 T cell responses regulate Salmonella persistence
-
批准号:8578801
-
项目类别:
-
资助金额:$35.37万
-
财政年份:2013
-
负责人:James B McLachlan
-
依托单位:
Antigen presentation to T cells in nonlymphoid tissue
-
批准号:7054953
-
项目类别:
-
资助金额:$4.88万
-
财政年份:2006
-
负责人:James B McLachlan
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: